Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug 27;6(8):596-600.
doi: 10.4254/wjh.v6.i8.596.

Pancreatic neuroendocrine tumor accompanied with multiple liver metastases

Tomohide Hori  1 , Kyoichi Takaori  1 , Shinji Uemoto  1
Affiliations
Review

Pancreatic neuroendocrine tumor accompanied with multiple liver metastases

Tomohide Hori et al. World J Hepatol. .

Abstract

Pancreatic neuroendocrine tumor (P-NET) is rare and slow-growing. Current classifications predict its prognosis and postoperative recurrence. Curative resection is ideal, although often difficult, because over 80% of patients have unresectable multiple liver metastases and extrahepatic metastasis. Aggressive surgery for liver metastases is important to improve survival. Aggressive or cytoreductive surgery for liver metastases is indicated to reduce hormone levels and improve symptoms and prognosis. Liver transplantation was originally conceived as an ideal therapy for unresectable liver metastases. Unfortunately, there is no clear consensus on the role and timing of surgery for primary tumor and liver metastases. Surgeons still face questions in deciding the best surgical scenario in patients with P-NET with unresectable liver metastases.

Keywords: Gastroenteropancreatic neuroendocrine tumor; Liver metastasis; Liver surgery; Liver transplantation; Pancreas.

PubMed Disclaimer

References

    1. Kimura W, Tezuka K, Hirai I. Surgical management of pancreatic neuroendocrine tumors. Surg Today. 2011;41:1332–1343. - PubMed
    1. International Union Against Cancer (UICC) TNM classification of malignant tumors. 7th ed. Sobin LH, Gospodarowicz MK, Wittekind C, editors. Oxford: Wiley-Blackwell (New York); 2009.
    1. Heitz P, Komminoth P, Perren A, Klimstra D, Dayal Y. Tumors of the endocrine pancreas. In: De Lellis R, Lloyd R, Heitz P, Eng C., editors. World Health Organization classification of tumors: pathology and genetics of tumors of endocrine organs. 1st ed. Lyon: IARC Press; 2004. pp. 177–182.
    1. Bettini R, Mantovani W, Boninsegna L, Crippa S, Capelli P, Bassi C, Scarpa A, Pederzoli P, Falconi M. Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. Dig Liver Dis. 2009;41:49–55. - PubMed
    1. Bloomston M, Muscarella P, Shah MH, Frankel WL, Al-Saif O, Martin EW, Ellison EC. Cytoreduction results in high perioperative mortality and decreased survival in patients undergoing pancreatectomy for neuroendocrine tumors of the pancreas. J Gastrointest Surg. 2006;10:1361–1370. - PubMed

LinkOut - more resources